Clinicopathologic and molecular analysis of disseminated appendiceal mucinous neoplasms: Identification of factors predicting survival and proposed criteria for a three-tiered assessment of tumor grade

Modern Pathology

Volumn 27, Issue 11, 2014, Pages 1521-1539

  Davison, Jon M ^a   Choudry, Haroon A ^b   Pingpank, James F ^b   Ahrendt, Steven A ^b   Holtzman, Matthew P ^b   Zureikat, Amer H ^b   Zeh, Herbert J ^b   Ramalingam, Lekshmi ^b   Zhu, Benjamin ^a   Nikiforova, Marina ^a   Bartlett, David L ^b   Pai, Reetesh K ^a  

^a PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

appendix; disseminated peritoneal adenomucinosis; low grade mucinous neoplasm; mucinous adenocarcinoma; peritoneal mucinous carcinomatosis; pseudomyxoma peritonei

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ALLELIC IMBALANCE; APPENDIX TUMOR; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CELL COMPONENT; CHROMOSOME 17P; CHROMOSOME 18Q; CLINICAL ASSESSMENT; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DISSEMINATED APPENDICEAL MUCINOUS ADENOCARCINOMA; DISSEMINATED APPENDICEAL MUCINOUS NEOPLASM; EXON; FEMALE; FOLLOW UP; GENE MUTATION; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PATHOLOGIST; PERINEURAL INVASION; PRIORITY JOURNAL; VERY ELDERLY; ADENOCARCINOMA, MUCINOUS; APPENDICEAL NEOPLASMS; BIOPSY; CARCINOMA, SIGNET RING CELL; CHI SQUARE DISTRIBUTION; CLASSIFICATION; COMPARATIVE STUDY; EVALUATION STUDY; GENETICS; HETEROZYGOSITY LOSS; KAPLAN MEIER METHOD; MOLECULAR DIAGNOSIS; MORTALITY; MULTIVARIATE ANALYSIS; MUTATION; NUCLEOTIDE SEQUENCE; PATHOLOGY; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PROCEDURES; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; RISK FACTOR; SECONDARY; TUMOR INVASION; UNITED STATES;

KRAS PROTEIN, HUMAN; ONCOPROTEIN; RAS PROTEIN; TUMOR MARKER;

ADENOCARCINOMA, MUCINOUS; APPENDICEAL NEOPLASMS; BIOPSY; CARCINOMA, SIGNET RING CELL; CHI-SQUARE DISTRIBUTION; DNA MUTATIONAL ANALYSIS; HUMANS; KAPLAN-MEIER ESTIMATE; LOSS OF HETEROZYGOSITY; MOLECULAR DIAGNOSTIC TECHNIQUES; MULTIVARIATE ANALYSIS; MUTATION; NEOPLASM GRADING; NEOPLASM INVASIVENESS; PENNSYLVANIA; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROTO-ONCOGENE PROTEINS; RAS PROTEINS; RISK ASSESSMENT; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84926186861     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2014.37     Document Type: Article

References (30)

1. Chuaqui RF, Zhuang Z, Emmert-Buck MR, et al. Genetic analysis of synchronous mucinous tumors of the ovary and appendix. Hum Pathol 1996;27:165-171.
2. Ronnett BM, Shmookler BM, Diener-West M, et al. Immunohistochemical evidence supporting the appen-diceal origin of pseudomyxoma peritonei in women. Int J Gynecol Pathol 1997;16:1-9.
3. Teixeira MR, Qvist H, Giercksky KE, et al. Cytogenetic analysis of several pseudomyxoma peritonei lesions originating from a mucinous cystadenoma of the appendix. Cancer Genet Cytogenet 1997;93: 157-159.
4. Szych C, Staebler A, Connolly DC, et al. Molecular genetic evidence supporting the clonality and appen-diceal origin of Pseudomyxoma peritonei in women. Am J Pathol 1999;154:1849-1855.
5. Young RH, Gilks CB, Scully RE. Mucinous tumors of the appendix associated with mucinous tumors of the ovary and pseudomyxoma peritonei. A clinicopatho-logical analysis of 22 cases supporting an origin in the appendix. Am J Surg Pathol 1991;15:415-429.
6. Carr NJ, Finch J, Ilesley IC, et al. Pathology and prognosis in pseudomyxoma peritonei: a review of 274 cases. J Clin Pathol 2012;65:919-923.
7. Bradley RF, JHt Stewart, Russell GB, et al. Pseudomyx-oma peritonei of appendiceal origin: a clinicopatholo-gic analysis of 101 patients uniformly treated at a single institution, with literature review. Am J Surg Pathol 2006;30:551-559.
8. Pai RK, Beck AH, Norton JA, et al. Appendiceal mucinous neoplasms: clinicopathologic study of 116 cases with analysis of factors predicting recurrence. Am J Surg Pathol 2009;33:1425-1439.
9. Misdraji J, Yantiss RK, Graeme-Cook FM, et al. Appendiceal mucinous neoplasms: a clinicopathologic analysis of 107 cases. Am J Surg Pathol 2003;27: 1089-1103.
10. Ronnett BM, Yan H, Kurman RJ, et al. Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis. Cancer 2001;92:85-91.
11. Ronnett BM, Zahn CM, Kurman RJ, et al. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei". Am J Surg Pathol 1995; 19:1390-1408.
12. Baratti D, Kusamura S, Nonaka D, et al. Pseudomyx-oma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreduc-tive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol 2008;15: 526-534.
13. Carr NJ, McCarthy WF, Sobin LH. Epithelial noncarci-noid tumors and tumor-like lesions of the appendix. A clinicopathologic study of 184 patients with a multivariate analysis of prognostic factors. Cancer 1995;75:757-768.
14. Pai RK, Longacre TA. Appendiceal mucinous tumors and pseudomyxoma peritonei: histologic features, diagnostic problems, and proposed classification. Adv Anat Pathol 2005;12:291-311.
15. Chua TC, Moran BJ, Sugarbaker PH, et al. Early-and long-term outcome data of patients with pseudomyx-oma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol 2012;30: 2449-2456.
16. Yan TD, Black D, Savady R, et al. A systematic review on the efficacy of cytoreductive surgery and perio-perative intraperitoneal chemotherapy for pseudomyx-oma peritonei. Ann Surg Oncol 2007;14:484-492.
17. Bryant J, Clegg AJ, Sidhu MK, et al. Systematic review of the Sugarbaker procedure for pseudomyxoma peritonei. Br J Surg 2005;92:153-158.
18. McBride K, McFadden D, Osler T. Improved survival of patients with pseudomyxoma peritonei receiving intraperitoneal chemotherapy with cytoreductive surgery: a systematic review and meta-analysis. J Surg Res 2013;183:246-252.
19. Cole KL, Choudry HA, Jones HL, et al. Critical role of hyperthermic intraperitoneal chemoperfusion in the treatment of a patient with Pseudomyxoma peritonei. J Surg Oncol 2012;106:513-516.
20. Elias D, Gilly F, Quenet F, et al. Pseudomyxoma peritonei: a French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy. Eur J Surg Oncol 2010;36:456-462.
21. Shapiro JF, Chase JL, Wolff RA, et al. Modern systemic chemotherapy in surgically unresectable neoplasms of appendiceal origin: a single-institution experience. Cancer 2010;116:316-322.
22. Bijelic L, Kumar AS, Stuart OA, et al. Systemic chemotherapy prior to cytoreductive surgery and HIPEC for carcinomatosis from appendix cancer: impact on perioperative outcomes and short-term survival. Gastroenterol Res Pract 2012;2012:163284.
23. Sugarbaker PH, Bijelic L, Chang D, et al. Neoadjuvant FOLFOX chemotherapy in 34 consecutive patients with mucinous peritoneal carcinomatosis of appendi-ceal origin. J Surg Oncol 2010;102:576-581.
24. Carr NJ, Sobin LH. Adenocarcinoma of the appendix, In: Bosman FT, Carneiro CF, Hruban RH, Theise ND(eds) WHO Classiciation of Tumours of the Digestive System. IARC Press: Lyon, France; 2010, pp 122-125.
25. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (eds). AJCC Cancer Staging Manual. 7th Ed. Springer: Chicago, IL; 2010, pp 133-141.
26. Maheshwari V, Tsung A, Lin Y, et al. Analysis of loss of heterozygosity for tumor-suppressor genes can accurately classify and predict the clinical behavior of mucinous tumors arising from the appendix. Ann Surg Oncol 2006;13:1610-1616.
27. Stancu M, Wu TT, Wallace C, et al. Genetic alterations in goblet cell carcinoids of the vermiform appendix and comparison with gastrointestinal carcinoid tumors. Mod Pathol 2003;16:1189-1198.
28. Ramnani DM, Wistuba II, Behrens C, et al. K-ras and p53 mutations in the pathogenesis of classical and goblet cell carcinoids of the appendix. Cancer 1999;86:14-21.
29. Zauber P, Berman E, Marotta S, et al. Ki-ras gene mutations are invariably present in low-grade muci-nous tumors of the vermiform appendix. Scand J Gastroenterol 2011;46:869-874.
30. Yantiss RK, Panczykowski A, Misdraji J, et al. A comprehensive study of nondysplastic and dysplas-tic serrated polyps of the vermiform appendix. Am J Surg Pathol 2007;31:1742-1753.